Application of 3D Printed Prosthesis in Limb Salvage Surgery for Bone Tumors

Launched by HENAN CANCER HOSPITAL · Nov 14, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at how effective 3D-printed bone prostheses are for patients with malignant tumors, which are serious types of cancer that can affect bones. The goal is to follow patients at Henan Cancer Hospital over the next ten years to see how well the 3D-printed replacements work, including any complications that might arise after surgery and how well the patients can use their limbs afterward.

Anyone can participate in this study, regardless of age or gender, as long as they have been diagnosed with a malignant tumor and have received a 3D-printed bone prosthesis at the hospital. Since the trial is not yet recruiting, it’s a good opportunity for patients and their families to learn about this innovative treatment option. Participants can expect close monitoring of their recovery and limb function throughout the study, helping doctors understand the long-term benefits and challenges of using 3D-printed prosthetics in surgeries for bone tumors.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Men and women of all ages are welcome.
• • Pathologically confirmed in our hospital as a subtype of malignant tumor.
• • He received 3D printed bone prosthesis replacement in our hospital.
• Exclusion Criteria:
• • Not applicable.